NVO$40.002.20%0.86
After Hours: 39.97-0.03 -0.08%
Novo Nordisk Adr (NVO)
Date: 2026-10-30 16:00O: 39.61H: 40.10L: 39.54C: 40.00Vol: 15.17M
Novo Nordisk Adr stock is traded at $40.00, with a volume of 15,165,981. It is up +2.20% in the last 24 hours and up +5.51% over the past month. With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Previous Close:
$39.14
Open:
$39.61
24h Volume:
15,165,981
Relative Volume:
1.63
Market Cap:
$176.43B
Revenue:
$50.91B
Net Income/Loss:
$18.95B
P/E Ratio:
9.39
EPS:
$4.26
Net Cash Flow:
$1.92B
1W Performance:
+2.43%
1M Performance:
+5.51%
6M Performance:
-5.26%
1Y Performance:
-20.06%
1-Day Range:
$39.54$40.10
1-Week Range:
$37.96$40.10
52-Week Range:
$35.12$64.16
Novo Nordisk Adr Stock (NVO) Company Profile
Compare NVO vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVO Novo Nordisk Adr | $40.00 | $176.43B | $50.91B | $18.95B | $1.92B | $4.26 |
 LLY Lilly Eli Co | $1,417.54 | $1.26T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $273.20 | $657.68B | $97.93B | $21.04B | $17.80B | $8.63 |
 ABBV Abbvie Inc | $294.89 | $521.11B | $62.82B | $3.60B | $19.98B | $2.03 |
 MRK Merck Co Inc | $149.52 | $368.89B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $160.79 | $303.67B | $54.66B | $13.58B | $16.05B | $7.02 |
